Use of fludrocortisone for intradialytic hypotension

被引:5
作者
Seo, Yuri [1 ]
Jeung, Soomin [1 ]
Kang, Sun-myoung [1 ]
Yang, Won Seok [1 ]
Kim, Hyosang [1 ]
Kim, Soon Bae [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nephrol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
关键词
Fludrocortisone; Hypotension; Midodrine; Renal dialysis; ORTHOSTATIC HYPOTENSION; MINERALOCORTICOID THERAPY; HEMODIALYSIS-PATIENTS; POTASSIUM; HOMEOSTASIS; MORTALITY;
D O I
10.23876/j.krcp.2018.37.1.85
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Intradialytic hypotension during dialysis adversely affects a patient's prognosis and increases mortality. We report a case in which intradialytic hypotension that persisted after the administration of midodrine was relieved after the use of fludrocortisone. Administration of 0.2 mg of fludrocortisone occurred 30 minutes before dialysis. We compared 45 sessions of dialysis without fludrocortisone administration and 45 sessions of dialysis with fludrocortisone administration in one patient. The number of times in which systolic blood pressure became lower than 80 mmHg and the number of early terminations of dialysis due to a decrease in systolic blood pressure were higher in the sessions without fludrocortisone administration than in the sessions with fludrocortisone administration (P < 0.05). Fludrocortisone may be helpful for the treatment of intradialytic hypotension that does not respond to midodrine administration.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 14 条
[1]  
CHOBANIAN AV, 1979, NEW ENGL J MED, V301, P68, DOI 10.1056/NEJM197907123010202
[2]   FLUDROCORTISONE IN TREATMENT OF POSTURAL HYPOTENSION - ALTERED SENSITIVITY TO PRESSOR AGENTS [J].
DAVIES, IB ;
BANNISTER, RG ;
SEVER, PS ;
WILCOX, CS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (05) :P444-P445
[3]   Association of Intradialytic Blood Pressure Variability With Increased All-Cause and Cardiovascular Mortality in Patients Treated With Long-term Hemodialysis [J].
Flythe, Jennifer E. ;
Inrig, Jula K. ;
Shafi, Tariq ;
Chang, Tara I. ;
Cape, Kathryn ;
Dinesh, Kumar ;
Kunaparaju, Shrikanth ;
Brunelli, Steven M. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2013, 61 (06) :966-974
[4]   Current pharmacologic treatment for orthostatic hypotension [J].
Freeman, Roy .
CLINICAL AUTONOMIC RESEARCH, 2008, 18 (Suppl 1) :14-18
[5]   Potassium-lowering effect of mineralocorticoid therapy in patients undergoing hemodialysis [J].
Furuya, R ;
Kumagai, H ;
Sakao, T ;
Maruyama, Y ;
Hishida, A .
NEPHRON, 2002, 92 (03) :576-581
[6]   Population Pharmacokinetic-Pharmacodynamic Model of Oral Fludrocortisone and Intravenous Hydrocortisone in Healthy Volunteers [J].
Hamitouche, Noureddine ;
Comets, Emmanuelle ;
Ribot, Megane ;
Alvarez, Jean-Claude ;
Bellissant, Eric ;
Laviolle, Bruno .
AAPS JOURNAL, 2017, 19 (03) :727-735
[7]   A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients [J].
Kaisar, Mohammed O. ;
Wiggins, Kathryn J. ;
Sturtevant, Joanne M. ;
Hawley, Carmel M. ;
Campbell, Scott B. ;
Isbel, Nicole M. ;
Mudge, David W. ;
Bofinger, Andrew ;
Petrie, James J. B. ;
Johnson, David W. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (05) :809-814
[8]  
LYMAN N, 1983, KIDNEY INT, V23, P155
[9]  
Mercadal Lucile, 2005, Hemodial Int, V9, P338, DOI 10.1111/j.1542-4758.2005.01150.x
[10]   Pharmacologic options available to treat symptomatic intradialytic hypotension [J].
Perazella, MA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) :S26-S36